Tuesday, November 17, 2026

AI startup HACARUS raises Series B funding totaling 1.3 billion yen

HACARUS, a developer of AI solutions in the medical and industrial fields, has raised funds through a third-party allocation of new shares. This round of funding is the same round as the Series B round conducted in April 2020, bringing HACARUS' cumulative fundraising amount to approximately 1.3 billion yen.

The third-party allotment was subscribed to by MTG Ventures Inc., Resona Capital No. 6 Investment Business Partnership, Ohara Pharmaceutical Industry Co. In conjunction with this financing, the company also received loans from The Bank of Kyoto, Ltd. and Japan Finance Corporation.

Note: (*) indicates additional investment by existing shareholders

Use of funds raised this time

1) Strengthen R&D in materials informatics (MI) and drug discovery support
2) Recruitment of business development and consulting personnel to promote joint projects with major companies
3) Deployment of AI solutions developed for the Japanese market in Europe, North America, and Southeast Asia

In Materials Informatics, a method of materials development using information science, AI has been applied in recent years. However, since experiments are necessary to confirm the effectiveness of AI and the new materials presented, and each experiment takes several months, the challenge is how to arrive at the optimal new materials with fewer experiments.

Sparse modeling, which is the focus of HACARUS, provides a solution to these issues, and HACARUS is working on research and development of methods to arrive at optimal new materials in a short time by combining human experience and intuition with sparse modeling.

Source: Numazawa, H., Igarashi, Y., Sato, K., Imai, H. & Oaki, Y. Experiment-Oriented Materials Informatics for Efficient Exploration

In the field of drug discovery, as in the case of materials informatics, experiments are required to confirm the efficacy and toxicity of compounds proposed by AI, which can take several years including human trials.

Furthermore, in recent years, attention has focused on genomic drug discovery, a method to develop drugs with fewer side effects based on genomic information and patient reactivity information. HACARUS is also engaged in research and development of unique drug discovery support using sparse modeling in these fields.

Strengthen consulting for AI implementation

HACARUS will strengthen its consulting services to support the introduction of AI to companies by leveraging its expertise in the development and practical application of AI technologies for more than 100 companies and organizations. business impact analysis, requirement definition, data analysis, annotation, and model development prior to AI introduction, HACARUS will provide a one-stop service for all tasks required for AI implementation, including business impact analysis, requirement definition, data analysis, annotation, model development, and application prototyping prior to AI implementation.

HACARUS will help companies to successfully implement AI by making full use of our know-how of successful AI implementation cases. HACARUS will lead your company to successful implementation of AI by utilizing our accumulated know-how of successful AI implementation cases.

The company will also enhance its services for the training of human resources required for post-implementation AI operations. Through training programs, the company will rapidly develop data science personnel, which are in short supply in the corporate sector. This will enable companies to have their own personnel to operate AI on their own, and to apply AI to other issues within the company.

Role of Tokyo R&D Center

HACARUS opened its Tokyo R&D Center in October 2020. Until now, HACARUS has had a two-location structure, with its head office functions in Kyoto and application and system development in its Philippine subsidiary (in Manila), but in addition to this, HACARUS will conduct R&D in Tokyo in the areas that it will focus on in the future. The Tokyo R&D Center is located at CIC Tokyo (in Toranomon Hills).

The activities of the Tokyo R&D Center will be disseminated through papers and seminars. In addition, by moving into CIC Tokyo, the CIC Group will utilize its global network to establish ties with companies in other countries. In addition, CIC Tokyo will be able to develop services from an international perspective in an environment where global business can be conducted without having to leave Tokyo, and will serve as a foothold for CIC Tokyo to expand into the global market in the future.

About HACARUS Corporation

HACARUS was founded in Kyoto in 2014 as an AI venture. HACARUS' strength is its sparse modeling technology, which excels in feature extraction from small amounts of data and is highly interpretable; HACARUS applies this sparse modeling technology to AI.

Deep learning, which is now a mainstream AI technology, requires a large amount of data for learning, and the AI decision-making process is a black box. It also requires a large amount of computational resources during the learning phase, which means that analysis takes an enormous amount of time and consumes a lot of power.

HACARUS has solved such problems faced by deep learning with its unique AI technology. In addition, by using sparse modeling, HACARUS has been able to solve AI-related issues in a wide range of industries and business categories, and has worked on the development and practical application of AI technologies for more than 100 companies and organizations. Going forward, the company will continue to focus on further strengthening its AI technology platform and expanding sales of existing services, aiming for further business expansion.

name of companyHACARUS Corporation
EstablishmentJanuary 14, 2014
LocationHead Office: Room A, 5th floor, 12th Hase Bldg. 227 Hashibenkei-machi, Nakagyo-ku, Kyoto-shi, Kyoto
Tokyo R&D Center: CIC Tokyo, Toranomon Business Tower 15F, 1-17-1 Toranomon, Minato-ku, Tokyo
Kobe Laboratory (Wet Lab/Laboratory): 5-5-2, Minatojima-Minamimachi, Chuo-ku, Kobe, Japan KBIC
Philippines Subsidiary: 23F Tower 6789, 6789 Ayala Avenue, Makati City, Philippines
representativeKemma Fujiwara
uniform resouce locatorhttps://hacarus.com/ja/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。